Over the past week to two weeks, the stock has shown small fluctuations, mostly trading around $1.00–$1.30 range, with some volatility typical of biotech micro-caps.
The 20-day moving average is ~1.09, and the 200-day average is ~1.16, suggesting recent prices are roughly in line with recent trends.
FATE’s price is well below its 52-week high (~$1.94) and above its 52-week low (~$0.66) — still within that range.
$Fate Therap(FATE.US)
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
